A new Patient Involvement Panel for our clinical trial governance

CDD Panel

If you haven't already, join our involvement network. You'll be sent the latest opportunities to get involved in our work, like the CDD Patient Involvement (PI) Panel, plus many more! There's also news and updates from the team.

Sign up now

 

Please find out more about our Centre for Drug Development

 

The Centre for Drug Development (CDD) takes new drugs into early-phase clinical trials. They strive to design trials with the help and feedback of people affected by cancer to improve the experience for future participants.

The team wanted to build on existing activities and develop ways for people affected by cancer to influence trial governance. They worked with researchers, clinical staff and people affected by cancer to create the first CDD Patient Involvement (PI) Panel.

Brainstorming and initial ideas

The process for CDD began when we first brainstormed what Patient Involvement could look like in a more integrated setting. We worked with the CDD Patient Involvement Working Group to gather best practice examples.

We used this to consult our Research & Strategy Cancer Insights Panel to get early-stage ideas and advice. Using this initial feedback we took the following proposal to the CDD Leadership Team, highlighting the benefits and need for:

  • The creation of a medium-sized panel of people affected by cancer
  • PI representation directly into the Protocol and Safety Review Board (PSRB), which reviews all CDD trials before submission for regulatory and ethical approval.
  • Opportunities for PI to input into CDD’s strategy.

We agreed to pilot the panel for 18 months.

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think